Financial

MassMutual Ventures and AXA Strategic Ventures led the funding round, with participation from the series seed lead investor LaunchPad Digital Health.

The company will use the funds to accelerate development of its platform for the management of complex patients, as well as to manage its rapid growth.

By bringing the entire process online and partnering with medical boards, the company has managed to cut the 3-month verification process down to a few weeks.

The company is using predictive modeling that involves big data- and genomics-driven approach to help women optimize their fertility.

The strategic funding was led by a subsidiary of Independence Health Group, the parent company of Independence Blue Cross and McKesson Ventures.

The company's solution adapts to the specific and temporary conditions of the patient, fostering a behavioral change and improving the treatment compliance.

The company is cash flow positive and will use the funds to expand operations and accelerate the development of related consumer decision support products.

The company's solution medCPU Advisor acquires and processes both structured and unstructured data immediately as it is entered into a clinician's EMR system.

Humana's Innovation Group will pilot Welkin's solution on its population health management program for members who are in their 70s and have diabetes.

First it will go to San Francisco, and then in 2016, to other major metro areas; the company is also looking to partner with healthcare organizations.